In MCF-7 cells, the treatment with the TKI vandetanib was effective on tumor growth; this response is eliminated by dual knockdown of RET and EGFR, thus establishing a link between expression of RET/EGFR and response to TKIs. Here, EGFR is linked to neoplasm.